Cargando…

Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants

Parkinson’s disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5–10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Daleum, Kim, Hyejung, Choi, Dong-Joo, Bae, Yun-Hee, Lee, Byoung Dae, Son, Ilhong, Seol, Wongi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138308/
https://www.ncbi.nlm.nih.gov/pubmed/30460091
http://dx.doi.org/10.1080/19768354.2018.1453545
_version_ 1783355319360946176
author Nam, Daleum
Kim, Hyejung
Choi, Dong-Joo
Bae, Yun-Hee
Lee, Byoung Dae
Son, Ilhong
Seol, Wongi
author_facet Nam, Daleum
Kim, Hyejung
Choi, Dong-Joo
Bae, Yun-Hee
Lee, Byoung Dae
Son, Ilhong
Seol, Wongi
author_sort Nam, Daleum
collection PubMed
description Parkinson’s disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5–10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP(+) treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
format Online
Article
Text
id pubmed-6138308
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61383082018-11-20 Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants Nam, Daleum Kim, Hyejung Choi, Dong-Joo Bae, Yun-Hee Lee, Byoung Dae Son, Ilhong Seol, Wongi Anim Cells Syst (Seoul) Articles Parkinson’s disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5–10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP(+) treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide. Taylor & Francis 2018-03-22 /pmc/articles/PMC6138308/ /pubmed/30460091 http://dx.doi.org/10.1080/19768354.2018.1453545 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Nam, Daleum
Kim, Hyejung
Choi, Dong-Joo
Bae, Yun-Hee
Lee, Byoung Dae
Son, Ilhong
Seol, Wongi
Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants
title Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants
title_full Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants
title_fullStr Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants
title_full_unstemmed Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants
title_short Characterization of Parkinson’s disease-related pathogenic TMEM230 mutants
title_sort characterization of parkinson’s disease-related pathogenic tmem230 mutants
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138308/
https://www.ncbi.nlm.nih.gov/pubmed/30460091
http://dx.doi.org/10.1080/19768354.2018.1453545
work_keys_str_mv AT namdaleum characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants
AT kimhyejung characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants
AT choidongjoo characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants
AT baeyunhee characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants
AT leebyoungdae characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants
AT sonilhong characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants
AT seolwongi characterizationofparkinsonsdiseaserelatedpathogenictmem230mutants